Clinical Trial Update: PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is exploring prophylactic haloperidol to prevent delirium in patients identified as high risk, with current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Zuyderland Medisch Centrum | Conditions: Delirium | Phase 4 | Status: UNKNOWN